Showing results (341-350 of 463) with videos related to
Sort By:
Pageof 47
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.Journal of Pediatric Surgery|June 21, 2011
Brain lipid-binding protein: a marker of differentiation in neuroblastic tumorsGiuseppe Retrosi, Neil J Sebire, Mark Bishay, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2018
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross PresentationAnna Capsomidis, Gabriel Benthall, Heleen H Van Acker, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 2, 2025
Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLERaffi Tachdjian, Aleena Banerji, Paula J Busse, et al.Advances in Therapy|May 2, 2026
Comparative Efficacy of Recombinant C1 Inhibitor Versus Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks: A Matching-Adjusted Indirect Treatment ComparisonJohn Anderson, Nihal Narsipur, Douglas Jones, et al.F1000Research|February 22, 2022
Flow cytometry of bone marrow aspirates from neuroblastoma patients is a highly sensitive technique for quantification of low-level neuroblastomaNeha Jain, Shaista Sattar, Sarah Inglott, et al.British Journal of Haematology|June 14, 2016
Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmesDaniel A Morgenstern, Gulrukh Ahsan, Margaret Brocklesby, et al.Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.Frontline Gastroenterology|June 18, 2019
British society of gastroenterology Endoscopy Quality Improvement Programme (EQIP): overview and progressColin J Rees, Sara Koo, John Anderson, et al.Pageof 47